Balaxi Pharmaceuticals consolidated net profit declines 95.52% in the June 2025 quarter
Sales rise 7.80% to Rs 70.74 crore
Net profit of Balaxi Pharmaceuticals declined 95.52% to Rs 0.29 crore in the quarter ended June 2025 as against Rs 6.48 crore during the previous quarter ended June 2024. Sales rose 7.80% to Rs 70.74 crore in the quarter ended June 2025 as against Rs 65.62 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales70.7465.62 8 OPM %5.8715.38 -PBDT1.377.87 -83 PBT0.907.37 -88 NP0.296.48 -96Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 05 2025 | 3:44 PM IST